Try the modernized beta website. Learn more about the modernization effort.

Key Record Dates Identifier: NCT04250337
Brief Title: Safety and Efficacy of Lebrikizumab (LY3650150) in Combination With Topical Corticosteroid in Moderate-to-Severe Atopic Dermatitis. (ADhere)

First Submitted : January 30, 2020
First Submitted that Met QC Criteria : January 30, 2020
First Posted : January 31, 2020

Last Update Submitted that Met QC Criteria : October 19, 2021
Last Update Posted : October 20, 2021